Optimind Pharma Corp. (CSE:OMND)
0.0050
0.00 (0.00%)
Aug 5, 2025, 1:15 PM EDT
Optimind Pharma Company Description
Optimind Pharma Corp. provides psychedelic therapies in Canada.
The company offers psychedelic-like therapies for the treatment of post-traumatic stress syndrome, anxiety, depression, and other mental illnesses and disabilities through ketamine-assisted treatment and other psychedelic enhanced psychotherapy modalities.
It also prescribes medical cannabis and other alternative treatments for various medical ailments through its clinics.
Optimind Pharma Corp. is headquartered in Toronto, Canada.
Optimind Pharma Corp.
Country | Canada |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | David Goodman |
Contact Details
Address: 40 King Street West Toronto, Ontario M5H 3Y2 Canada | |
Phone | 647-891-9379 |
Website | optimindpharma.com |
Stock Details
Ticker Symbol | OMND |
Exchange | Canadian Securities Exchange |
Fiscal Year | March - February |
Reporting Currency | CAD |
ISIN Number | CA68405U1012 |
SIC Code | 8000 |
Key Executives
Name | Position |
---|---|
David Goodman | Chief Executive Officer and Director |
Rakesh Malhotra (US), B.Com., C.A., C.P.A., CA (Canada), F.C.A., F | Chief Financial Officer and Secretary |